What Happened

A licensed pharmacist who owned and operated Allen's Pharmacy in Dothan, Alabama, was sentenced to 87 months in federal prison after admitting he sold Schedule II opioids directly to customers for cash instead of dispensing them against valid prescriptions.

In November 2019, the Dothan Police Department Narcotics Division received an anonymous tip that someone was selling prescription medications without a prescription out of the pharmacy. A joint investigation by Dothan PD and the Drug Enforcement Administration found that the pharmacy's own owner was selling oxycodone and hydrocodone outside the pharmacy's dispensing records, direct to individuals in exchange for cash.

A federal grand jury indicted the pharmacist in July 2020, and he pleaded guilty in January 2021. As part of his plea, he specifically admitted that on one occasion he sold 14 hydrocodone pills to a customer for cash without a valid prescription. He was sentenced to 87 months in prison and three years of supervised release.

What Went Wrong

  • The registrant was the diverter. The pharmacist-in-charge and owner of the pharmacy was the one selling controlled substances outside legitimate channels, so there was no independent pharmacist oversight to catch the conduct.
  • Sales weren't tied to verified prescriptions. Controlled substances were sold directly to individuals with no prescription on file, bypassing the basic corresponding-responsibility check every dispensing pharmacist must perform.
  • Detection depended entirely on an outside tip. The scheme wasn't surfaced by any internal control, inventory reconciliation, or state prescription drug monitoring program review — it took a private citizen's tip to local police to trigger the investigation.

How It Could Have Been Prevented

  • Independent, periodic reconciliation of controlled substance inventory against purchase and dispensing records, performed by someone other than the owner or pharmacist-in-charge.
  • Routine cross-checks of dispensing logs against the state prescription drug monitoring program to confirm every unit sold corresponds to a valid, traceable prescription.
  • External or corporate compliance audits for independently owned pharmacies, since a sole owner-pharmacist has no internal check on their own dispensing decisions.
  • Clear channels for employees, patients, and the public to report suspected diversion directly to the DEA or state pharmacy board, not just local police.

Related Guidance

Sources